Amphastar Pharmaceuticals, Inc. (AMPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.25B |
| Enterprise Value | 1.74B |
| P/E Ratio | 12.92 |
| PEG Ratio | -3.04 |
| Price/Sales Ratio | 1.66 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 2.31 |
| Enterprise/EBITDA | 7.81 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.13 |
| Operating Margin | 0.19 |
| Return On Assets | 0.06 |
| Return On Equity | 0.13 |
| Revenue | 719.89M |
| Revenue/Share | 17.52 |
| Gross Profit | 356.06M |
| EBITDA | 212.31M |
| Net Income | 98.09M |
| Diluted EPS | 2.03 |
| Total Cash | 230.63M |
| Total Cash/Share | 5.42 |
| Total Debt | 691.69M |
| Total Debt/Equity | 0.85 |
| Current Ratio | 3.32 |
| Book Value Per Share | 19.13 |
| 52-Week Change | 11.26 |
| 52-Week High | 31 |
| 52-Week Low | 16.65 |
| Moving Average 50 Days | 25.5 |
| Moving Average 200 Days | 22.3 |
| Average Volume | 466,625 |
| Shares Outstanding | 42.54M |
| % Held by Institutions | 63.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |